<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04286009</url>
  </required_header>
  <id_info>
    <org_study_id>19-011417</org_study_id>
    <nct_id>NCT04286009</nct_id>
  </id_info>
  <brief_title>Pathogenesis and Mechanisms of Mitral Annular Calcification</brief_title>
  <official_title>Pathogenesis and Mechanisms of Mitral Annular Calcification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are testing blood or mitral valve tissue to better understand the reasons why
      Mitral Annular Calcification (MAC) develops in patients with heart disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim is to test the hypothesis that Endothelial Progenitor Cells osteoblastic phenotype
      (EPC-OCNs) play a significant role in the process of Mitral Annular Calcification (MAC) as
      prognostic markers of calcific cardiac valves.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 18, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prognostic markers of calcific cardiac valves</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured by Endothelial Progenitor Cells osteoblastic phenotype (EPC-OCNs) in Mitral Annular Calcification (MAC)</description>
  </primary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Mitral Annulus Calcification</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood

      Tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects referred to the Mayo Clinic valve clinic, with or without MAC. Also, subjects
        undergoing surgery, either standard surgical MVR or trans-atrial TMVR.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with diagnosis of MAC and patients coming to the Valve Clinic without MAC
             diagnosis Patients who will undergo surgery, either standard surgical MVR or
             trans-atrial TMVR, with diagnosis of MAC or without diagnosis of MAC

        Exclusion Criteria:

          -  Subjects unwilling to participate or to provide consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Amir Lerman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rachel Geroux</last_name>
    <phone>(507) 266-3180</phone>
    <email>geroux.rachel@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diana Albers</last_name>
    <phone>(507) 255-6133</phone>
    <email>Albers.Diana2@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Geroux</last_name>
      <phone>507-266-3180</phone>
      <email>geroux.rachel.@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Amir Lerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 25, 2020</study_first_submitted>
  <study_first_submitted_qc>February 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2020</study_first_posted>
  <last_update_submitted>April 9, 2020</last_update_submitted>
  <last_update_submitted_qc>April 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Amir Lerman</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcinosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

